Article info
PDFPostScript
Letter
A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies
- Correspondence to Dr Davids Fridmanis, Latvian Biomedical Research and Study Centre, Ratsupites 1K-1, LV-1067, Riga, Latvia; davids{at}biomed.lu.lv and Professor Lars Engstrand, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 77, Sweden; lars.engstrand{at}ki.se
Citation
A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies
Publication history
- Received February 9, 2018
- Revised August 8, 2018
- Accepted August 26, 2018
- First published September 21, 2018.
Online issue publication
November 14, 2019
Article Versions
- Previous version (7 August 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.